Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Highlight Edit

RTR42HZZ
Making An Ebola Vaccine - 15 Aug 2014
Click here for a Full Edit

Icon Genetics, a German company, is developing technology to mass produce Ebola Vaccine with the help of tobacco plants.
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FWM
August 14, 2014
Laboratory technicians of the company Icon Genetics prepare proteins from tobacco plants (Nicotiana benthamiana)...
Berlin, Germany
Laboratory technicans of the company Icon Genetics prepare proteines from Tobacco plants (Nicotiana benthamiana)...
Laboratory technicians of the company Icon Genetics prepare proteins from tobacco plants (Nicotiana benthamiana) for weighing in a laboratory in Halle, Germany August 14, 2014. Icon Genetics GmbH, a German biopharma firm, is helping in the fight against the deadly virus Ebola, by creating antibodies needed for the experimental drug known as ZMapp. REUTERS/Axel Schmidt
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FWI
August 14, 2014
A laboratory technician at Icon Genetics prepares proteins from tobacco plants for weighing in a laboratory...
Berlin, Germany
A laboratory technican of the company Icon Genetics prepares proteines from Tobacco plants (Nicotiana...
A laboratory technician at Icon Genetics prepares proteins from tobacco plants for weighing in a laboratory in Halle, August 14, 2014. Scientists at the company have created so-called vectors - DNA used to make plants create antibodies - which are put into bacteria and then transferred into tobacco plants, or nicotiana benthamiana. REUTERS/Axel Schmidt
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FW7
August 14, 2014
A tobacco plant is pictured in a laboratory at Icon Genetic in Halle, August 14, 2014. During a week's...
Berlin, Germany
A Tobacco plant (Nicotiana benthamiana) is pictured in a laboratory of the company Icon Genetic in Halle...
A tobacco plant is pictured in a laboratory at Icon Genetic in Halle, August 14, 2014. During a week's incubation period in a greenhouse, the plants produce antibodies for the Ebola virus. These antibodies are then extracted from the plant and the waste plant material is discarded. The antibodies can then be used in the drug Zmapp. REUTERS/Axel Schmidt
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FVP
August 14, 2014
Victor Klimyuk, COO of Icon Genetics inspects tobacco plants in a laboratory in Halle, August 14, 2014....
Berlin, Germany
Klimyuk, COO of the company Icon Genetics inspects Tobacco plants (Nicotiana benthamiana) in a laboratory...
Victor Klimyuk, COO of Icon Genetics inspects tobacco plants in a laboratory in Halle, August 14, 2014. Klimyuk says the process can be used for fighting many different viruses or illnesses and that it is practical because it can be scaled up easily. REUTERS/Axel Schmidt
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FWG
August 14, 2014
Laboratory technicians at Icon Genetics prepare tobacco plants for drying in a laboratory in Halle, August...
Berlin, Germany
Laboratory technicans of the company Icon Genetics prepare Tobacco plants (Nicotiana benthamiana) for...
Laboratory technicians at Icon Genetics prepare tobacco plants for drying in a laboratory in Halle, August 14, 2014. There are no licensed treatments or vaccines for Ebola, a contagious hemorrhagic disease, but several biotech companies and research teams have been working on potential drugs. REUTERS/Axel Schmidt
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FV6
August 14, 2014
Victor Klimyuk, COO of Icon Genetics, speaks during an interview in a laboratory in Halle, August 14,...
Berlin, Germany
Klimyuk, COO of the company Icon Genetics, speaks during an interview in a laboratory in Halle
Victor Klimyuk, COO of Icon Genetics, speaks during an interview in a laboratory in Halle, August 14, 2014. So far only 10-12 doses of ZMapp have been made. REUTERS/Axel Schmidt
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FW9
August 14, 2014
A sign is placed on a greenhouse with tobacco plants at Icon Genetic in Halle, August 14, 2014. The WHO's...
Berlin, Germany
A sign is placed on a greenhouse with Tobacco plants (Nicotiana benthamiana) at the company Icon Genetic...
A sign is placed on a greenhouse with tobacco plants at Icon Genetic in Halle, August 14, 2014. The WHO's panel of medical ethicists said several experimental drugs had passed the laboratory and animal study phases of development and should be fast-tracked into clinical trials and made available for compassionate use. REUTERS/Axel Schmidt
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FW4
August 14, 2014
A sign at Icon Genetics is pictured in Halle, August 14, 2014. REUTERS/Axel Schmidt
Berlin, Germany
A sign of the company Icon Genetics is pictured in Halle
A sign at Icon Genetics is pictured in Halle, August 14, 2014. REUTERS/Axel Schmidt
Display
Items per page
Page
of 1